サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1702958

バイオ医薬品発酵システムの世界市場レポート 2025年

Biopharmaceutical Fermentation Systems Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオ医薬品発酵システムの世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオ医薬品発酵システム市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.3％で383億9,000万米ドルに成長します。予測期間の成長は、バイオ医薬品パイプラインの拡大、個別化医療へのシフト、連続バイオプロセスの採用、新興市場の拡大、自動化とデジタル化の進展に起因すると考えられます。予測期間における主な動向には、連続製造の採用拡大、個別化医療の成長、バイオシミラー市場の拡大、高度な分析とAIの採用、持続可能性と環境への影響の重視などがあります。

生物製剤パイプラインの拡大が、今後数年間のバイオ医薬品発酵システム市場の成長を牽引します。生物製剤には、ワクチン、遺伝子治療薬、組換え治療用タンパク質など、生物またはその構成要素に由来する医薬品が含まれます。生物製剤パイプラインのこのような成長は、バイオテクノロジーの進歩、疾病メカニズムに対するより深い洞察、標的治療や個別化治療に対する需要の増加によって促進されています。バイオ医薬品発酵システムは、遺伝子操作された細胞や微生物を培養することにより、複雑な治療用タンパク質、抗体、ワクチンの大規模合成を可能にし、生物製剤生産において重要な役割を果たしています。例えば、2023年に食品医薬品局（FDA）は、29の新規化学物質（NCE）と25の新規生物学的製剤（NBE）を含む55の新薬を承認し、2022年の37の承認と比較して50％の増加を示しました。したがって、生物製剤パイプラインの成長がバイオ医薬品発酵システム市場を前進させています。

生物製剤発酵システム市場の主なプレーヤーは、効率性、拡張性、再現性を向上させるために、自動バイオリアクターなどの先進システムの開発に注力しています。自動バイオリアクターは、バイオ医薬品製造における微生物や細胞の増殖条件を最適化するための自動制御・監視技術を統合したものです。例えば、フランスを拠点とする実験機器メーカーであるFoilabo社は、2022年10月に完全自動化ラボスケール・バイオリアクターを発売しました。これらのバイオリアクターは、様々な用途に対応できる汎用性と精度を備えており、インペラーの配置や種類をカスタマイズできるオプションで、高品位の無菌状態を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界バイオ医薬品発酵システムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のバイオ医薬品発酵システム市場：成長率分析
  • 世界のバイオ医薬品発酵システム市場の実績：規模と成長, 2019-2024
  • 世界のバイオ医薬品発酵システム市場の予測：規模と成長, 2024-2029, 2034F
  • 世界バイオ医薬品発酵システム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のバイオ医薬品発酵システム市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 上流製品
  • 下流製品
  • 世界のバイオ医薬品発酵システム市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 組み換えタンパク質
  • モノクローナル抗体
  • 抗生物質
  • プロバイオティクス
  • その他の用途
  • 世界のバイオ医薬品発酵システム市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バイオ医薬品企業
  • 契約製造組織
  • 契約調査機関
  • 学術調査機関
  • 食品業界
  • その他のエンドユーザー
  • 世界のバイオ医薬品発酵システム市場上流製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 発酵槽またはバイオリアクター
  • 文化メディア
  • 接種物調製システム
  • ガスおよび液体の流量制御システム
  • プロセス監視および制御システム
  • 滅菌システム
  • 世界のバイオ医薬品発酵システム市場下流製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ろ過システム
  • 遠心分離機
  • クロマトグラフィーシステム
  • 限外濾過システムと精密濾過システム
  • 濃縮・精製システム
  • 包装および保管システム

第7章 地域別・国別分析

  • 世界のバイオ医薬品発酵システム市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のバイオ医薬品発酵システム市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • バイオ医薬品発酵システム市場：競合情勢
  • バイオ医薬品発酵システム市場：企業プロファイル
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Becton Dickinson and Company
  • GE Healthcare
  • Agilent Technologies Inc.
  • Lonza Group AG
  • GEA Group AG
  • Sartorius Stedim Biotech
  • Bio-Rad Laboratories Inc.
  • Pall Corporation
  • Nova Biomedical
  • Eppendorf AG
  • Repligen Corporation
  • ZETA Holding GmbH
  • New Brunswick Scientific
  • ABEC Inc.
  • Pierre Guerin Technologies

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • バイオ医薬品発酵システム市場2029：新たな機会を提供する国
  • バイオ医薬品発酵システム市場2029：新たな機会を提供するセグメント
  • バイオ医薬品発酵システム市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r29614

A biopharmaceutical fermentation system is a specialized arrangement designed to cultivate microorganisms or cells for the production of biopharmaceutical products in controlled environments. These systems are crucial in the biomanufacturing process, facilitating the generation of biologically active compounds such as proteins, antibodies, vaccines, and other therapeutic agents. Key components of biopharmaceutical fermentation systems include bioreactors or fermenters, which create optimal conditions for cell growth and product formation by regulating factors such as temperature, pH, oxygen levels, and nutrient availability.

The primary products of biopharmaceutical fermentation systems can be categorized into upstream and downstream products. Upstream products encompass materials, equipment, or processes involved in the initial production stages, focusing on raw materials, cultivation, and early manufacturing processes. These systems find applications in producing various substances such as recombinant proteins, monoclonal antibodies, antibiotics, probiotics, among others. End-users of these products include biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, the food industry, and other relevant sectors.

The biopharmaceutical fermentation systems market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical fermentation systems market statistics, including biopharmaceutical fermentation systems industry global market size, regional shares, competitors with biopharmaceutical fermentation systems market share, detailed biopharmaceutical fermentation systems market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical fermentation systems industry. This biopharmaceutical fermentation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical fermentation systems market size has grown strongly in recent years. It will grow from $24.61 billion in 2024 to $26.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing demand for biologics, regulatory support, industry consolidation, growing investment in research and developments, and evolving healthcare landscape.

The biopharmaceutical fermentation systems market size is expected to see strong growth in the next few years. It will grow to $38.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to expansion of biopharmaceutical pipeline, shift towards personalized medicine, adoption of continuous bioprocessing, emerging market expansion, and advancements in automation and digitalization. Major trends in the forecast period include increased adoption of continuous manufacturing, growth in personalized medicine, expansion of biosimilars market, adoption of advanced analytics and AI, and focus on sustainability and environmental impact.

The expansion of the biologics pipeline is set to drive the growth of the biopharmaceutical fermentation systems market in the coming years. Biologics encompass medicinal products derived from living organisms or their components, including vaccines, gene therapies, and recombinant therapeutic proteins. This growth in the biologics pipeline is fueled by advancements in biotechnology, deeper insights into disease mechanisms, and the increasing demand for targeted and personalized therapies. Biopharmaceutical fermentation systems play a crucial role in biologics production by cultivating genetically engineered cells or microorganisms, enabling the large-scale synthesis of complex therapeutic proteins, antibodies, and vaccines. For example, in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Hence, the growing biologics pipeline is propelling the biopharmaceutical fermentation systems market forward.

Key players in the biologics fermentation systems market are focusing on developing advanced systems such as automated bioreactors to improve efficiency, scalability, and reproducibility. Automated bioreactors integrate automated control and monitoring technologies to optimize growth conditions for microorganisms or cells in biopharmaceutical production. For instance, Froilabo, a France-based laboratory equipment company, launched fully automated lab-scale bioreactors in October 2022. These bioreactors offer versatility and precision for various applications, providing high-grade aseptic conditions with customizable options for impeller placement and type.

In December 2022, MilliporeSigma, a US-based life sciences company, acquired Erbi Biosystems Inc., enhancing its upstream portfolio in therapeutic proteins. This acquisition integrated Erbi Biosystems' Breez micro-bioreactor platform technology, facilitating scalable cell-based perfusion bioreactor processes from 2ml to 2000L and promoting innovation in continuous bioprocessing. Erbi Biosystems Inc. is a US-based company specializing in bioprocess instrumentation for cell therapy and bioprocessing process development.

Major companies operating in the biopharmaceutical fermentation systems market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., Lonza Group AG, GEA Group AG, Sartorius Stedim Biotech, Bio-Rad Laboratories Inc., Pall Corporation, Nova Biomedical, Eppendorf AG, Repligen Corporation, ZETA Holding GmbH, New Brunswick Scientific, ABEC Inc., Pierre Guerin Technologies, AntoXa Corporation, Applikon Biotechnology, Cellexus Ltd., Infors HT, BioPharm Process Associates LLC

North America was the largest region in the biopharmaceutical fermentation systems market in 2024. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical fermentation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical fermentation system market consists of revenues earned by entities by providing services such as analytical services, maintenance services, regulatory support, contract manufacturing, and integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biopharmaceutical fermentation systems market also includes sales of bioreactors, media and buffers, and microorganisms and cell lines which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Fermentation Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical fermentation systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical fermentation systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical fermentation systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Upstream Products; Downstream Products
  • 2) By Application: Recombinant Proteins; Monoclonal Antibodies; Antibiotics; Probiotics; Other Applications
  • 3) By End-User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Academic Research Institutes; Food Industry; Other End-Users
  • Subsegments:
  • 1) By Upstream Products: Fermenters Or Bioreactors; Culture Media; Inoculum Preparation Systems; Gas And Liquid Flow Control Systems; Process Monitoring And Control Systems; Sterilization Systems
  • 2) By Downstream Products: Filtration Systems; Centrifuges; Chromatography Systems; Ultrafiltration And Microfiltration Systems; Concentration And Purification Systems; Packaging And Storage Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; 3M Company; Danaher Corporation; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biopharmaceutical Fermentation Systems Market Characteristics

3. Biopharmaceutical Fermentation Systems Market Trends And Strategies

4. Biopharmaceutical Fermentation Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biopharmaceutical Fermentation Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biopharmaceutical Fermentation Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biopharmaceutical Fermentation Systems Market Growth Rate Analysis
  • 5.4. Global Biopharmaceutical Fermentation Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biopharmaceutical Fermentation Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biopharmaceutical Fermentation Systems Total Addressable Market (TAM)

6. Biopharmaceutical Fermentation Systems Market Segmentation

  • 6.1. Global Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Upstream Products
  • Downstream Products
  • 6.2. Global Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Recombinant Proteins
  • Monoclonal Antibodies
  • Antibiotics
  • Probiotics
  • Other Applications
  • 6.3. Global Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
  • Academic Research Institutes
  • Food Industry
  • Other End-Users
  • 6.4. Global Biopharmaceutical Fermentation Systems Market, Sub-Segmentation Of Upstream Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fermenters Or Bioreactors
  • Culture Media
  • Inoculum Preparation Systems
  • Gas And Liquid Flow Control Systems
  • Process Monitoring And Control Systems
  • Sterilization Systems
  • 6.5. Global Biopharmaceutical Fermentation Systems Market, Sub-Segmentation Of Downstream Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Filtration Systems
  • Centrifuges
  • Chromatography Systems
  • Ultrafiltration And Microfiltration Systems
  • Concentration And Purification Systems
  • Packaging And Storage Systems

7. Biopharmaceutical Fermentation Systems Market Regional And Country Analysis

  • 7.1. Global Biopharmaceutical Fermentation Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biopharmaceutical Fermentation Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical Fermentation Systems Market

  • 8.1. Asia-Pacific Biopharmaceutical Fermentation Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical Fermentation Systems Market

  • 9.1. China Biopharmaceutical Fermentation Systems Market Overview
  • 9.2. China Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical Fermentation Systems Market

  • 10.1. India Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical Fermentation Systems Market

  • 11.1. Japan Biopharmaceutical Fermentation Systems Market Overview
  • 11.2. Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical Fermentation Systems Market

  • 12.1. Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical Fermentation Systems Market

  • 13.1. Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical Fermentation Systems Market

  • 14.1. South Korea Biopharmaceutical Fermentation Systems Market Overview
  • 14.2. South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical Fermentation Systems Market

  • 15.1. Western Europe Biopharmaceutical Fermentation Systems Market Overview
  • 15.2. Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical Fermentation Systems Market

  • 16.1. UK Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical Fermentation Systems Market

  • 17.1. Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical Fermentation Systems Market

  • 18.1. France Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical Fermentation Systems Market

  • 19.1. Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical Fermentation Systems Market

  • 20.1. Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical Fermentation Systems Market

  • 21.1. Eastern Europe Biopharmaceutical Fermentation Systems Market Overview
  • 21.2. Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical Fermentation Systems Market

  • 22.1. Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical Fermentation Systems Market

  • 23.1. North America Biopharmaceutical Fermentation Systems Market Overview
  • 23.2. North America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical Fermentation Systems Market

  • 24.1. USA Biopharmaceutical Fermentation Systems Market Overview
  • 24.2. USA Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical Fermentation Systems Market

  • 25.1. Canada Biopharmaceutical Fermentation Systems Market Overview
  • 25.2. Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical Fermentation Systems Market

  • 26.1. South America Biopharmaceutical Fermentation Systems Market Overview
  • 26.2. South America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical Fermentation Systems Market

  • 27.1. Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical Fermentation Systems Market

  • 28.1. Middle East Biopharmaceutical Fermentation Systems Market Overview
  • 28.2. Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical Fermentation Systems Market

  • 29.1. Africa Biopharmaceutical Fermentation Systems Market Overview
  • 29.2. Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biopharmaceutical Fermentation Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical Fermentation Systems Market Competitive Landscape And Company Profiles

  • 30.1. Biopharmaceutical Fermentation Systems Market Competitive Landscape
  • 30.2. Biopharmaceutical Fermentation Systems Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical Fermentation Systems Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. GE Healthcare
  • 31.3. Agilent Technologies Inc.
  • 31.4. Lonza Group AG
  • 31.5. GEA Group AG
  • 31.6. Sartorius Stedim Biotech
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Pall Corporation
  • 31.9. Nova Biomedical
  • 31.10. Eppendorf AG
  • 31.11. Repligen Corporation
  • 31.12. ZETA Holding GmbH
  • 31.13. New Brunswick Scientific
  • 31.14. ABEC Inc.
  • 31.15. Pierre Guerin Technologies

32. Global Biopharmaceutical Fermentation Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Fermentation Systems Market

34. Recent Developments In The Biopharmaceutical Fermentation Systems Market

35. Biopharmaceutical Fermentation Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Biopharmaceutical Fermentation Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biopharmaceutical Fermentation Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biopharmaceutical Fermentation Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer